Back to Trades
Stoppel Laura
DirectorCIK 0001865119
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Stoppel Laura, Director, has disclosed $121.9K in transactions — all concentrated in Acumen Pharmaceuticals, Inc. (ABOS). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jun 5 | ABOS Acumen Pharmaceuticals, Inc. | Stoppel Laura | Director | Grant | $121.9K |
1 filing